given a four-week course of daily sessions of oxygen at 2 atmospheres for one hour, six days a week.
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His rigidity was less marked following hyperbaric oxygen treatment. However, the mild improvements were sustained for only a few hours and the signs of severe parkinsonism returned shortly after treatment. Eventually, he was transferred to a continuing-care ward, dependent in all aspects of nursing care. COMMENT This case illustrates the hazards of carbon monoxide poisoning and in particular delayed neurological deterioration. The severity of carbon monoxide poisoning should be judged from clinical findings since the level of carboxyhaemoglobin is a poor indicator. This patient had clear early evidence of carbon monoxide poisoning; immediate treatment with hyperbaric oxygen therapyl'2 might have prevented subsequent neurological deterioration. Several studies have shown that hyperbaric oxygenation can reverse both the acute3 and the delayed4 effects of carbon monoxide poisoning. The time course in this patient was characteristic for the delayed effects of carbon monoxide poisoning. Nearly all such patients resume full activity in four or five days, followed by a clear and seemingly normal interval of two to ten days. Patients then become abruptly apathetic and confused, with walking changing to a halting shuffle and diffuse skeletal muscle rigidity4. Deaths may occur as late as one month after poisoning.
Hyperbaric oxygen therapy is 100% oxygen delivered at two to three times the atmospheric pressure at sea level5. It is the fastest method of reversing the potentially life threatening effects of acute carbon monoxide poisoning and patients with severe carbon monoxide poisoning should receive at least one treatment with hyperbaric oxygen at 2.5-3 atmospheres; additional treatments may produce greater improvement in neuropsychological deficits.
The toxic effects of carbon monoxide poisoning have been attributed primarily to its reduction of the oxygen transport capacity of haemoglobin, by its reversible binding to haemoglobin in place of oxygen-forming carboxyhaemoglobin. Free radicals and damage to the electron transport chain have been implicated in the pathogenesis of parkinsonism. Hyperbaric oxygen administration seems to prevent neuronal injury by mediating the dissociation of carbon monoxide from the enzyme cytochrome P oxidase6. Myocardial rupture complicates 3% of all myocardial infarctions and is the cause of death in 17% of fatal infarctsl. By comparison, false left ventricular aneurysm is uncommon, with an unknown prevalence and natural history2. It results from rupture of a densely adherent full thickness infarct, with containment of the resulting haematoma.
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CASE HISTORY
A man aged 49 was referred in April 1997 with a threeweek history of progressive dyspnoea on exertion and epigastric pain radiating to his neck and back. During the subsequent 18 months he became more troubled, with paroxysmal nocturnal dyspnoea and easy fatiguability. He had undergone 4-vessel coronary bypass surgery in February 1990.
On admission in October 1998 electrocardiography showed T wave inversion in the lateral leads and a chest radiograph revealed an asymmetrically enlarged left ventricle. Echocardiography demonstrated a large inferolateral aneurysm with a layer of mural thrombus. On cardiac angiography his native coronary arteries were occluded but a left internal mammary artery graft to the left anterior descending artery was patent with good In rheumatoid arthritis (RA), granulomata affecting the heart were described more than fifty years agol, but there are few reports of rheumatoid valvar disease severe enough to require surgical intervention2-. The pathological picture may be inflammation with dilatation of the annulus or fibrosis with contraction and destruction of the valve leaflets.
A woman aged 41 was admitted with acute pulmonary oedema. For six months she had been increasingly short of breath on exertion, with orthopnoea and mild ankle oedema; and for S years she had been treated for aggressive seronegative rheumatoid arthritis with erosive changes in the small joints of the hands, knees and ankles, receiving methotrexate 10 mg once a week and prednisolone 7.5 mg per day. The rheumatoid factor had been negative at presentation and remained so (Rose-Waaler serum test, BioMerieux, Basingstoke, UK); antinuclear antibody was also absent. Her medical history included spontaneous closure of a congenital cardiac septal defect. Between the ages of 13 and 19 she had had two episodes of juvenile arthritis.
